Empowered Funds LLC Takes $27.21 Million Position in Cigna Group $CI

Empowered Funds LLC purchased a new stake in Cigna Group (NYSE:CI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 98,708 shares of the health services provider’s stock, valued at approximately $27,212,000.

Other institutional investors also recently bought and sold shares of the company. Assetmark Inc. grew its position in Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after acquiring an additional 5,963 shares in the last quarter. Mystic Asset Management Inc. acquired a new stake in Cigna Group during the 2nd quarter valued at $2,808,000. KBC Group NV grew its holdings in Cigna Group by 6.4% during the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after purchasing an additional 22,978 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in Cigna Group during the 2nd quarter worth $11,043,000. Finally, HighTower Advisors LLC boosted its position in Cigna Group by 402.7% in the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after buying an additional 283,897 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Down 1.3%

NYSE:CI opened at $277.21 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The company has a market capitalization of $73.25 billion, a price-to-earnings ratio of 11.47, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The stock has a 50-day simple moving average of $283.53 and a 200 day simple moving average of $281.41.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of analyst reports. Guggenheim lifted their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Wolfe Research restated an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Barclays raised their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Robert W. Baird set a $362.00 price target on shares of Cigna Group in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $339.45.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 in the last 90 days. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.